Insights

Global API Leader Divi’s Laboratories is a large, export-focused API manufacturer with a multi-country footprint and a track record of supplying to regulated markets like the US and Europe, presenting opportunities to upsell high-volume API supply, custom synthesis, and scale partnerships.

Expansion Drive Recent capacity expansion plans and new facility openings in India indicate ongoing investment in manufacturing capabilities, signaling opportunities for contract manufacturing, capacity-backed collaborations, and long-term supply agreements.

Financial Momentum Quarterly net profit growth and robust revenue progression suggest improving financial health, enabling discussions around larger, multi-year API supply contracts, risk-sharing production models, and pricing terms favorable to scale.

Strategic Partnerships Strengthening custom synthesis capabilities and partnerships with global innovators point to demand for specialized synthetic routes, scale-up capabilities, and white-label or tolling arrangements for complex APIs and intermediates.

Digital & Compliance Readiness Adoption of cloud and e-commerce tech stacks alongside a focus on regulated markets implies a readiness to engage through digital procurement platforms, streamlined onboarding, and compliance-ready supplier programs, reducing time-to-market for new API ventures.

Similar companies to DIVIS LABORATORIES

DIVIS LABORATORIES Tech Stack

DIVIS LABORATORIES uses 8 technology products and services including iCIMS, Amazon Web Services, Sucuri, and more. Explore DIVIS LABORATORIES's tech stack below.

Media & News

DIVIS LABORATORIES's Email Address Formats

DIVIS LABORATORIES uses at least 7 email formats:
DIVIS LABORATORIES Email FormatsExamplePercentage
LFirst@divislaboratories.comDJohn@divislaboratories.com
70%
Last@divislaboratories.comDoe@divislaboratories.com
12%
FirstLast@divislaboratories.comJohnDoe@divislaboratories.com
9%
First@divislaboratories.comJohn@divislaboratories.com
9%
First@divislabs.comJohn@divislabs.com
73%
First.Last@divislabs.comJohn.Doe@divislabs.com
25%
First.MiddleLast@divislabs.comJohn.MichaelDoe@divislabs.com
2%

Frequently Asked Questions

What is DIVIS LABORATORIES's phone number?

Minus sign iconPlus sign icon
You can contact DIVIS LABORATORIES's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DIVIS LABORATORIES's official website and social media links?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's official website is divislabs.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does DIVIS LABORATORIES generate?

Minus sign iconPlus sign icon
As of August 2026, DIVIS LABORATORIES's annual revenue is estimated to be $100M - $250M.

What is DIVIS LABORATORIES's SIC code and NAICS code?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does DIVIS LABORATORIES have currently?

Minus sign iconPlus sign icon
As of August 2026, DIVIS LABORATORIES has approximately 3.6K employees across 4 continents, including Asia, North America and Europe. Key team members include Chief Executive Officer: K. D., Ceo Managing Director: D. H. and Chief Executive Officer: A. S. Explore DIVIS LABORATORIES's employee directory with LeadIQ.

What industry does DIVIS LABORATORIES belong to?

Minus sign iconPlus sign icon
DIVIS LABORATORIES operates in the Pharmaceutical Manufacturing industry.

What technology does DIVIS LABORATORIES use?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's tech stack includes iCIMS, Amazon Web Services, Sucuri, WordPress, Shopify, Mailchimp, Select2 and Piwik PRO Core.

What is DIVIS LABORATORIES's email format?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's email format typically follows the pattern of LFirst@divislaboratories.com. Find more DIVIS LABORATORIES email formats with LeadIQ.

How much funding has DIVIS LABORATORIES raised to date?

Minus sign iconPlus sign icon
As of August 2026, DIVIS LABORATORIES has raised $4.4M in funding. The last funding round occurred on Nov 07, 2022 for $4.4M.

When was DIVIS LABORATORIES founded?

Minus sign iconPlus sign icon
DIVIS LABORATORIES was founded in 1990.
DIVIS LABORATORIES logo

DIVIS LABORATORIES

Pharmaceutical ManufacturingTelangana, India1001-5000 Employees

Divi's Laboratories Limited is a pharmaceutical manufacturer that produces generic active pharmaceutical ingredients, nutraceutical ingredients, and custom synthesis of APIs and intermediates for global customers, with exports directed mainly to regulated markets in the US and Europe. Headquartered in Hyderabad, Telangana, India, the company operates multiple manufacturing facilities to support its international reach.

The company serves customers by supplying generic APIs and related ingredients and by performing tailored synthesis work to meet specific API needs. Recent developments include the start of commercial operations at its Unit III greenfield facility in Kakinada, Andhra Pradesh, underscoring ongoing capacity expansion. Divi's maintains a global presence, with operations across three manufacturing sites and a footprint in more than 100 countries.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1990
Employees
1001-5000

Section iconFunding & Financials

  • $4.4M

    DIVIS LABORATORIES has raised a total of $4.4M of funding over 1 rounds. Their latest funding round was raised on Nov 07, 2022 in the amount of $4.4M as a Post IPO Equity.

  • $100M - $250M

    DIVIS LABORATORIES's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.